Randomised Study to Compare the Efficacy of AZD6244 vs TMZ

NCT00338130 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

239

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma

Interventions

DRUG: AZD6244
DRUG: Temozolomide

Sponsor

AstraZeneca